US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
NZ257212A
(en)
*
|
1992-09-29 |
1996-11-26 |
Inhale Therapeutic Syst |
Parathyroid hormone formulations comprising a biologically active n-terminal fragment of the hormone
|
PT748213E
(pt)
*
|
1994-03-07 |
2004-08-31 |
Nektar Therapeutics |
Metodos e composicoes para administracao pulmonar de insulina
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
NZ285664A
(en)
*
|
1994-05-18 |
1998-07-28 |
Inhale Therapeutic Syst |
Dry powder interferon composition adapted for pulmonary delivery
|
US6290991B1
(en)
*
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
*
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6565885B1
(en)
*
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US6598603B1
(en)
*
|
1997-12-31 |
2003-07-29 |
Astra Aktiebolag |
Method for treating respiratory diseases
|
GB9827145D0
(en)
*
|
1998-12-09 |
1999-02-03 |
Co Ordinated Drug Dev |
Improvements in or relating to powders
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
US6858199B1
(en)
*
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
ATE545652T1
(de)
*
|
1999-06-29 |
2012-03-15 |
Mannkind Corp |
Reinigung und stabilisierung von proteinen und peptiden in pharmaceutischen agentien
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US6846819B1
(en)
|
1999-10-08 |
2005-01-25 |
Affinium Pharmaceuticals, Inc. |
Fab I inhibitors
|
ATE461692T1
(de)
*
|
1999-10-29 |
2010-04-15 |
Novartis Ag |
Trockenpulverzusammensetzungen mit verbesserter dispersität
|
DE60140121D1
(de)
*
|
2000-02-11 |
2009-11-19 |
Respironics Respiratory Drug D |
Wirkstoffabgabevorrichtung
|
US8820316B2
(en)
*
|
2000-02-11 |
2014-09-02 |
Respironics Respiratory Drug Delivery (Uk) Ltd |
Drug delivery apparatus
|
PE20011227A1
(es)
*
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
WO2001085136A2
(fr)
|
2000-05-10 |
2001-11-15 |
Alliance Pharmaceutical Corporation |
Poudres a base de phospholipides permettant de distribuer un medicament
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
PT1913939T
(pt)
|
2000-06-27 |
2017-07-19 |
Vectura Ltd |
Formulações para utilização em dispositivos inalatórios
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
WO2002011695A2
(fr)
|
2000-08-07 |
2002-02-14 |
Inhale Therapeutic Systems, Inc. |
Poudres a inhaler de proteines en faisceau a quatre helices sechees par atomisation presentant une agregation reduite au minimum
|
US6677347B2
(en)
*
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
JP2004517127A
(ja)
|
2000-12-21 |
2004-06-10 |
ネクター セラピューティックス |
ポリエン抗真菌剤の肺送達
|
US7138419B2
(en)
*
|
2000-12-27 |
2006-11-21 |
Corus Pharma, Inc. |
Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
|
US7214364B2
(en)
|
2000-12-27 |
2007-05-08 |
Corus Pharma, Inc. |
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
CA2433280C
(fr)
*
|
2000-12-27 |
2010-09-21 |
Salus Pharma, Inc. |
Aztreonam inhalable destine au traitement et a la prevention d'infections bacteriennes pulmonaires
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US7049310B2
(en)
*
|
2001-04-06 |
2006-05-23 |
Affinium Pharmaceuticals, Inc. |
Fab I inhibitors
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
WO2002094229A1
(fr)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Administration de myorelaxants par voie respiratoire
|
EP1392262A1
(fr)
*
|
2001-05-24 |
2004-03-03 |
Alexza Molecular Delivery Corporation |
Administration d'esters medicamenteux par inhalation
|
EG24184A
(en)
*
|
2001-06-15 |
2008-10-08 |
Otsuka Pharma Co Ltd |
Dry powder inhalation system for transpulmonary
|
ATE358179T1
(de)
*
|
2001-06-15 |
2007-04-15 |
Takeda Pharmaceutical |
Polypeptid mit zelltodhemmender wirkung
|
WO2003035028A1
(fr)
*
|
2001-10-19 |
2003-05-01 |
Nektar Therapeutics |
Modulation de la densite de charge pour ameliorer les caracteristiques de proteines sechees par pulverisation
|
AU2002335046A1
(en)
*
|
2001-10-19 |
2003-05-06 |
Inhale Therapeutic Systems, Inc. |
The use of proton sequestering agents in drug formulations
|
AUPR879601A0
(en)
*
|
2001-11-09 |
2001-12-06 |
Biota Scientific Management Pty Ltd |
Novel chemical compounds and their use
|
EP1458360B1
(fr)
|
2001-12-19 |
2011-05-11 |
Novartis AG |
Administration pulmonaire d'aminoglycosides
|
DE10206770A1
(de)
*
|
2002-02-19 |
2003-08-28 |
Boehringer Ingelheim Pharma |
Verfahren zur Herstellung eines Pulverinhalativums enthaltend ein Salz des CGRP-Antagonisten BIBN4096
|
US6900317B2
(en)
*
|
2002-02-19 |
2005-05-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
|
US20040014679A1
(en)
*
|
2002-02-20 |
2004-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof
|
DE10207026A1
(de)
*
|
2002-02-20 |
2003-08-28 |
Boehringer Ingelheim Kg |
Pulverinhalativum, enthaltend den CGRP-Antagonisten BIBN4096 und Verfahren zu dessen Herstellung
|
ES2300568T3
(es)
*
|
2002-03-20 |
2008-06-16 |
Mannkind Corporation |
Aparato de inhalacion.
|
CA2478974C
(fr)
*
|
2002-03-20 |
2014-12-16 |
Advanced Inhalation Research, Inc. |
Formulations therapeutiques soutenues respirables
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
MXPA05005921A
(es)
*
|
2002-12-02 |
2005-10-19 |
Abgenix Inc |
Anticuerpos dirigidos a factor de necrosis tumoral y sus usos.
|
ES2518316T3
(es)
*
|
2002-12-06 |
2014-11-05 |
Debiopharm International Sa |
Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
|
EA009775B1
(ru)
*
|
2002-12-13 |
2008-04-28 |
Оцука Фармасьютикал Ко., Лтд. |
Новая порошковая ингаляционная система для чрезлегочного введения
|
JP2004238392A
(ja)
*
|
2003-01-14 |
2004-08-26 |
Nipro Corp |
安定化された蛋白質性製剤
|
SI1594500T1
(sl)
*
|
2003-02-10 |
2011-02-28 |
Bayer Schering Pharma Ag |
Zdravljenje bakterijskih bolezni dihalnih organov z lokalno aplikacijo fluorokinolonov
|
DE602004016831D1
(de)
|
2003-03-17 |
2008-11-13 |
Affinium Pharm Inc |
Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
|
US20050008580A1
(en)
*
|
2003-04-09 |
2005-01-13 |
Wyeth |
Hemophilia treatment by inhalation of coagulation factors
|
US20040214851A1
(en)
*
|
2003-04-28 |
2004-10-28 |
3M Innovative Properties Company |
Compositions and methods for induction of opioid receptors
|
EP1625334B9
(fr)
|
2003-05-21 |
2012-07-25 |
Alexza Pharmaceuticals, Inc. |
Unité de chauffage autonome allumée par percussion
|
AU2004251623B2
(en)
*
|
2003-05-28 |
2010-03-18 |
Novartis Ag |
Spray drying of an alcoholic aqueous solution for the manufacture of a water-in-soluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat
|
US7648997B2
(en)
*
|
2003-08-12 |
2010-01-19 |
Coley Pharmaceutical Group, Inc. |
Hydroxylamine substituted imidazoquinolines
|
DE10339197A1
(de)
*
|
2003-08-22 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
|
NZ545412A
(en)
*
|
2003-08-27 |
2008-12-24 |
Coley Pharm Group Inc |
Aryloxy and arylalkyleneoxy substituted imidazoquinolines
|
US20050054665A1
(en)
*
|
2003-09-05 |
2005-03-10 |
3M Innovative Properties Company |
Treatment for CD5+ B cell lymphoma
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
WO2005025535A2
(fr)
*
|
2003-09-15 |
2005-03-24 |
Vectura Limited |
Procedes de preparation de compositions pharmaceutiques
|
US7544697B2
(en)
*
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
US20090075980A1
(en)
*
|
2003-10-03 |
2009-03-19 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and Analogs Thereof
|
BRPI0414856A
(pt)
*
|
2003-10-03 |
2006-11-21 |
3M Innovative Properties Co |
imidazoquinolinas alcóxi-substituìdas
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
US7897767B2
(en)
|
2003-11-14 |
2011-03-01 |
3M Innovative Properties Company |
Oxime substituted imidazoquinolines
|
CN1906192A
(zh)
*
|
2003-11-14 |
2007-01-31 |
3M创新有限公司 |
羟胺取代的咪唑环化合物
|
KR101130928B1
(ko)
*
|
2003-11-25 |
2012-04-12 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
치환된 이미다조 고리 시스템 및 방법
|
DE10358387A1
(de)
*
|
2003-12-13 |
2005-07-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
|
US20060182692A1
(en)
|
2003-12-16 |
2006-08-17 |
Fishburn C S |
Chemically modified small molecules
|
CA2758460C
(fr)
*
|
2003-12-16 |
2014-09-23 |
Nektar Therapeutics |
Methodes de preparation de compositions de reactifs oligo (ethylene glycol) monodisperses
|
EP1701955A1
(fr)
*
|
2003-12-29 |
2006-09-20 |
3M Innovative Properties Company |
Imidazoquinolines a substitution arylalcenyle et arylalkynyle
|
WO2005066169A2
(fr)
*
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
EP1729724A4
(fr)
|
2003-12-31 |
2008-07-23 |
Cydex Inc |
Formulation inhalable contenant de l'ether sulfoalkyle g-cyclodextrine et un corticosteroide
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
EP1701714A2
(fr)
|
2004-01-07 |
2006-09-20 |
Nektar Therapeutics |
Compositions a liberation prolongee amelioree pour la delivrance de proteines pharmaceutiques
|
CN101027082A
(zh)
*
|
2004-01-12 |
2007-08-29 |
曼恩坎德公司 |
降低2型糖尿病患者血清胰岛素原水平的方法
|
ES2398318T3
(es)
*
|
2004-03-12 |
2013-03-15 |
Biodel, Inc. |
Composiciones de suministro de fármacos de acción rápida
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
EP1730751B1
(fr)
*
|
2004-03-12 |
2009-10-21 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
Milieu magnetoresistant
|
US8697873B2
(en)
*
|
2004-03-24 |
2014-04-15 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
SE528121C2
(sv)
*
|
2004-03-29 |
2006-09-05 |
Mederio Ag |
Preparering av torrpulver för på förhand uppmätt DPI
|
LT2708225T
(lt)
|
2004-04-23 |
2019-04-10 |
Cydex Pharmaceuticals, Inc. |
Dpi kompozicija, turinti sulfoalkilo eterio ciklodekstrino
|
US20060039985A1
(en)
*
|
2004-04-27 |
2006-02-23 |
Bennett David B |
Methotrexate compositions
|
US7727962B2
(en)
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
US7723306B2
(en)
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
US7611709B2
(en)
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
WO2007053131A2
(fr)
|
2004-06-04 |
2007-05-10 |
Affinium Pharmaceuticals, Inc. |
Agents thérapeutiques et méthodes pour les fabriquer et les utiliser
|
US8017779B2
(en)
*
|
2004-06-15 |
2011-09-13 |
3M Innovative Properties Company |
Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
WO2006038923A2
(fr)
*
|
2004-06-18 |
2006-04-13 |
3M Innovative Properties Company |
Imidazonaphthyridines substituees par aryle
|
WO2006065280A2
(fr)
*
|
2004-06-18 |
2006-06-22 |
3M Innovative Properties Company |
Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole
|
US8026366B2
(en)
*
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
KR101276754B1
(ko)
|
2004-07-19 |
2013-06-19 |
바이오콘 리미티드 |
인슐린―올리고머 접합체,제형 및 이들의 용도
|
WO2006033713A2
(fr)
*
|
2004-08-09 |
2006-03-30 |
Chiron Corporation |
Procedes destines a l'inhalation de ciprofloxacine
|
CA2575692C
(fr)
|
2004-08-20 |
2014-10-14 |
Mannkind Corporation |
Catalyse de la synthese de dicetopiperazine
|
KR20130066695A
(ko)
|
2004-08-23 |
2013-06-20 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
WO2006025395A1
(fr)
*
|
2004-08-31 |
2006-03-09 |
Yasuhiko Shimizu |
Médicament et système de traitement pour une bronchopneumopathie chronique obstructive en utilisant un facteur de croissance des cellules sans porteur
|
WO2006026760A2
(fr)
*
|
2004-09-02 |
2006-03-09 |
3M Innovative Properties Company |
Composes renfermant un 1-amino imidazo et procedes
|
WO2007011396A2
(fr)
*
|
2004-10-29 |
2007-01-25 |
President And Fellows Of Harvard College |
Particules pour le traitement d'infections pulmonaires
|
JP2008523076A
(ja)
*
|
2004-12-08 |
2008-07-03 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫調節性の組成物、合剤、および方法
|
JP5543068B2
(ja)
*
|
2004-12-30 |
2014-07-09 |
スリーエム イノベイティブ プロパティズ カンパニー |
キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
|
ES2392648T3
(es)
|
2004-12-30 |
2012-12-12 |
3M Innovative Properties Company |
Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
|
JP2008530022A
(ja)
|
2005-02-04 |
2008-08-07 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫反応調節物質を含む水性ゲル処方物
|
WO2006086634A2
(fr)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
|
EP1869043A2
(fr)
|
2005-04-01 |
2007-12-26 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridine-1,4-diamines et analogues associes
|
JP2008538550A
(ja)
|
2005-04-01 |
2008-10-30 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての1−置換ピラゾロ(3,4−c)環状化合物
|
US7838532B2
(en)
|
2005-05-18 |
2010-11-23 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US8546423B2
(en)
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
HUE038814T2
(hu)
|
2005-05-18 |
2018-11-28 |
Horizon Orphan Llc |
Aeroszolizált fluor-kinolonok és alkalmazásaik
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
CN104324362B
(zh)
|
2005-09-14 |
2018-04-24 |
曼金德公司 |
以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
ITMI20051999A1
(it)
|
2005-10-21 |
2007-04-22 |
Eratech S R L |
Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
JP2009518399A
(ja)
*
|
2005-12-05 |
2009-05-07 |
アフィニウム ファーマシューティカルズ, インク. |
Fabi阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
|
US8293869B2
(en)
|
2005-12-16 |
2012-10-23 |
Nektar Therapeutics |
Polymer conjugates of GLP-1
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
LT1991201T
(lt)
*
|
2006-02-10 |
2018-07-25 |
Pari Pharma Gmbh |
Puškiami antibiotikai inhaliaciniam gydymui
|
EP1986674A4
(fr)
*
|
2006-02-13 |
2009-11-11 |
Nektar Therapeutics |
Compositions protéiques ou peptidiques protéine contenant de la méthionine et leur procédé de fabrication et d'utilisation
|
CA2642641A1
(fr)
*
|
2006-02-15 |
2007-08-23 |
Tika Laekemedel Ab |
Melange de corticosteroides stable
|
MX2008010721A
(es)
|
2006-02-22 |
2008-09-01 |
Mannkind Corp |
Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
|
AU2007238114B2
(en)
*
|
2006-04-12 |
2010-10-14 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
ES2386972T3
(es)
*
|
2006-05-31 |
2012-09-10 |
Genzyme Corporation |
Uso de polisacáridos para la estimulación de la actividad enzimática
|
WO2008008432A2
(fr)
*
|
2006-07-12 |
2008-01-17 |
Coley Pharmaceutical Group, Inc. |
Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
|
CA2658506C
(fr)
|
2006-07-20 |
2016-01-26 |
Affinium Pharmaceuticals, Inc. |
Derives d'acrylamide en tant qu'inhibiteurs de fab 1
|
FR2904532B1
(fr)
*
|
2006-08-03 |
2012-10-19 |
Soc Extraction Principes Actif |
Composition dermatologique et/ou cosmetique contenant des polypeptides ou des peptides
|
WO2008025560A1
(fr)
*
|
2006-09-01 |
2008-03-06 |
Pari Pharma Gmbh |
Procédés servant à masquer le goût de compositions nébulisées pour thérapie par inhalation nasale et pulmonaire
|
DK2066341T3
(en)
*
|
2006-09-01 |
2015-10-19 |
Csl Ltd |
PROCEDURE FOR INITIATING OR INDUCING AN IMMUNE RESPONSE
|
US8263613B2
(en)
*
|
2007-02-16 |
2012-09-11 |
Affinium Pharmaceuticals, Inc. |
Salts, prodrugs and polymorphs of fab I inhibitors
|
ES2594867T3
(es)
|
2007-03-09 |
2016-12-23 |
Alexza Pharmaceuticals, Inc. |
Unidad de calentamiento para usar en un dispositivo de administración de fármaco
|
WO2008137747A1
(fr)
|
2007-05-02 |
2008-11-13 |
The Regents Of The University Of Michigan |
Compositions thérapeutiques à base de nanoémulsion et leurs procédés d'utilisation
|
AU2008269140A1
(en)
|
2007-06-26 |
2008-12-31 |
Merck Sharp & Dohme Corp. |
Lyophilized anti-fungal composition
|
CA2702094C
(fr)
|
2007-10-10 |
2018-05-01 |
Parion Sciences, Inc. |
Administration d'osmolytes par canule nasale
|
NZ583377A
(en)
*
|
2007-10-12 |
2013-11-29 |
Csl Ltd |
Method of eliciting an immune response against pandemic influenza virus
|
US20090175840A1
(en)
*
|
2008-01-04 |
2009-07-09 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
WO2009120619A2
(fr)
*
|
2008-03-24 |
2009-10-01 |
Novartis Ag |
Compositions de nucléase, procédés de préparation et d’utilisation de ces compositions, et systèmes d’administration pulmonaire de ces compositions
|
WO2009143011A1
(fr)
*
|
2008-05-20 |
2009-11-26 |
Novartis Ag |
Compositions antivirales, procédés de fabrication et d’utilisation de ces compositions, et système de délivrance pulmonaire de ces compositions
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
US8424518B2
(en)
|
2008-06-13 |
2013-04-23 |
Mannkind Corporation |
Dry powder inhaler and system for drug delivery
|
EP2609954B1
(fr)
|
2008-06-20 |
2021-12-29 |
MannKind Corporation |
Appareil interactif pour l'établissement en temps réel d'un profil des efforts d'inhalation
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
US20110171312A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Modified therapeutic peptides, methods of their preparation and use
|
EP2350118B1
(fr)
|
2008-09-19 |
2016-03-30 |
Nektar Therapeutics |
Polymères à base de glucide pour administration de médicaments et leurs conjugués
|
CA2738245A1
(fr)
*
|
2008-09-26 |
2010-04-01 |
Nanobio Corporation |
Compositions therapeutiques de nanoemulsion et procedes d'utilisation de celles-ci
|
CN102325532B
(zh)
|
2008-10-07 |
2015-06-17 |
Mpex医药有限公司 |
用于减轻肺部炎症的左氧氟沙星吸入剂
|
JP2012505223A
(ja)
|
2008-10-07 |
2012-03-01 |
エムペックス・ファーマシューティカルズ・インコーポレーテッド |
薬物動態の改善のためのエアゾールフルオロキノロン配合物
|
CA2743904A1
(fr)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Compositions de vaccins contre le cancer et leurs methodes d'utilisation
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
JP5667095B2
(ja)
|
2009-03-11 |
2015-02-12 |
マンカインド コーポレイション |
吸入器の抵抗を測定するための装置、システムおよび方法
|
CN102497853B
(zh)
|
2009-03-26 |
2018-03-23 |
普马特里克斯营业公司 |
治疗肺病的干粉配方与方法
|
US9539233B2
(en)
*
|
2009-05-04 |
2017-01-10 |
Aridis Pharmaceuticals Inc. |
Gallium formulation for the treatment and prevention of infectious diseases
|
DK2435024T3
(en)
|
2009-05-29 |
2016-10-24 |
Pearl Therapeutics Inc |
Compositions for the respiratory delivery of active agents and related methods and systems
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
EP2440251A4
(fr)
|
2009-06-09 |
2013-01-16 |
Defyrus Inc |
Administration d'interféron pour une prophylaxie contre une infection pathogène ou un traitement d'une infection pathogène
|
KR20180036807A
(ko)
|
2009-06-12 |
2018-04-09 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
LT2473170T
(lt)
|
2009-09-04 |
2019-10-10 |
Horizon Orphan Llc |
Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui
|
WO2011056889A1
(fr)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
Appareil et méthode de simulation d'efforts d'inhalation
|
US9072783B2
(en)
|
2009-11-18 |
2015-07-07 |
Aridis Pharmaceuticals |
Highly dispersible powders, compositions and methods for preparation
|
US20110233469A1
(en)
*
|
2009-12-21 |
2011-09-29 |
Brent Petersen |
Leucine/Peptide Composition and Method of Formulation
|
CN103003422B
(zh)
|
2010-04-20 |
2015-02-11 |
奥克塔法马股份有限公司 |
用于药物蛋白的新型稳定剂
|
CA2801936C
(fr)
|
2010-06-21 |
2021-06-01 |
Mannkind Corporation |
Systeme et procede d'administration de medicament sous la forme d'une poudre seche
|
EP2464346A1
(fr)
|
2010-08-30 |
2012-06-20 |
Pulmatrix, Inc. |
Méthodes de traitement de la mucoviscidose
|
EP2611438B1
(fr)
|
2010-08-30 |
2020-04-01 |
Pulmatrix Operating Company, Inc. |
Formulations de poudre sèche et méthodes de traitement de maladies pulmonaires
|
DK2621488T3
(en)
|
2010-09-29 |
2019-03-04 |
Pulmatrix Operating Co Inc |
CATIONIC DRY POWDER
|
RU2017144619A
(ru)
|
2010-09-29 |
2019-02-20 |
Пулмэтрикс, Инк. |
Катионы одновалентных металлов сухих порошков для ингаляций
|
AU2011336413B2
(en)
|
2010-12-02 |
2015-01-22 |
Oncolytics Biotech Inc. |
Liquid viral formulations
|
KR102023207B1
(ko)
|
2010-12-02 |
2019-11-25 |
온콜리틱스 바이오테크 인코포레이티드 |
동결건조 바이러스 제형
|
ES2645769T3
(es)
|
2011-01-05 |
2017-12-07 |
Hospira, Inc. |
Secado por pulverización de la vancomicina
|
AU2012212269B2
(en)
|
2011-01-31 |
2016-05-19 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
US10358043B2
(en)
*
|
2011-03-31 |
2019-07-23 |
Elite Power Solutions, LLC |
Golf cart battery system
|
CN103826988B
(zh)
|
2011-04-01 |
2016-03-09 |
曼金德公司 |
用于药物药盒的泡罩包装
|
MX346244B
(es)
*
|
2011-05-19 |
2017-03-13 |
Savara Inc |
Composiciones de vancomicina en polvo seco y metodos asociados.
|
US9572774B2
(en)
*
|
2011-05-19 |
2017-02-21 |
Savara Inc. |
Dry powder vancomycin compositions and associated methods
|
JP6219271B2
(ja)
|
2011-06-07 |
2017-10-25 |
パリオン・サイエンシィズ・インコーポレーテッド |
治療の方法
|
KR20150116468A
(ko)
*
|
2011-06-07 |
2015-10-15 |
아사히 가세이 파마 가부시키가이샤 |
고순도 pth 함유 동결 건조 제제 및 그의 제조 방법
|
US8945605B2
(en)
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
WO2012174472A1
(fr)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
Microparticules de dicétopipérazine de capacité élevée
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
AU2012328885B2
(en)
|
2011-10-24 |
2017-08-31 |
Mannkind Corporation |
Methods and compositions for treating pain
|
MX2014007277A
(es)
|
2011-12-16 |
2014-07-28 |
Novartis Ag |
Aparato de aerosolizacion para administracion de farmaco independiente del perfil de inhalacion.
|
KR101342485B1
(ko)
*
|
2012-02-29 |
2013-12-17 |
미원상사주식회사 |
트리펩타이드 및 이를 함유하는 노화방지, 주름개선, 미백 및 항염효능의 화장료 조성물
|
CN109999013A
(zh)
|
2012-02-29 |
2019-07-12 |
普马特里克斯营业公司 |
可吸入干粉剂
|
WO2013176622A1
(fr)
*
|
2012-05-21 |
2013-11-28 |
Agency For Science, Technology And Research (A*Star) |
Formulation de poudre sèche
|
CA2872029A1
(fr)
|
2012-05-29 |
2013-12-05 |
Parion Sciences, Inc. |
Amino-amides de type dendrimeres possedant une activite de blocage des canaux sodiques pour le traitement de la secheresse oculaire et d'autres maladies des muqueuses
|
RS58898B1
(sr)
|
2012-06-19 |
2019-08-30 |
Debiopharm Int Sa |
Prolek derivati (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamida
|
AU2013289957B2
(en)
|
2012-07-12 |
2017-02-23 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
WO2014066856A1
(fr)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Compositions et procédés de vaccin antigrippal inhalable
|
CA2896686A1
(fr)
|
2012-12-17 |
2014-06-26 |
Parion Sciences, Inc. |
Composes 3,5-diamino -6-chloro-n-(n- (4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide
|
KR20150095870A
(ko)
|
2012-12-17 |
2015-08-21 |
패리온 사이언스 인코퍼레이티드 |
3,5-디아미노-6-클로로-n-(n-(4-페닐부틸)카르밤이미도일)피라진-2-카르복스아미드 화합물
|
DK2931713T3
(en)
|
2012-12-17 |
2017-01-30 |
Parion Sciences Inc |
CHLORPYRAZINE CARBOXAMIDE DERIVATIVES USED FOR THE TREATMENT OF DISEASES BENEFITED BY INDEPENDENT MOSPHEREWIN
|
CA2906817C
(fr)
|
2013-03-15 |
2022-01-18 |
Mannkind Corporation |
Compositions de dicetopiperazine microcristallines et procedes
|
US20140275517A1
(en)
|
2013-03-15 |
2014-09-18 |
Pearl Therapeutics, Inc. |
Methods and systems for conditioning of particulate crystalline materials
|
CN104043104B
(zh)
|
2013-03-15 |
2018-07-10 |
浙江创新生物有限公司 |
含盐酸万古霉素的喷雾干粉及其工业化制备方法
|
WO2014165303A1
(fr)
|
2013-04-01 |
2014-10-09 |
Pulmatrix, Inc. |
Poudres sèches de tiotropium
|
RU2015154720A
(ru)
|
2013-05-22 |
2017-06-27 |
Перл Терапьютикс, Инк. |
Композиции, способы и системы для респираторной доставки трех или более активных средств
|
MX2016000739A
(es)
*
|
2013-07-18 |
2017-04-06 |
Mannkind Corp |
Composiciones farmacéuticas en polvo seco estables al calor y métodos.
|
CA3172586A1
(fr)
|
2013-07-31 |
2015-02-05 |
Avalyn Pharma Inc. |
Composes d'imatinib en aerosol et utilisations connexes
|
CA2920488C
(fr)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Appareil d'insufflation et procedes
|
NZ722927A
(en)
|
2014-01-10 |
2022-07-29 |
Avalyn Pharma Inc |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
WO2015148905A1
(fr)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Utilisation d'insuline à action ultrarapide
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
ES2924988T3
(es)
|
2014-10-10 |
2022-10-13 |
Univ Michigan Regents |
Composiciones con nanoemulsiones para prevenir, inhibir o eliminar una enfermedad alérgica e inflamatoria
|
TN2018000293A1
(en)
|
2016-02-26 |
2020-01-16 |
Debiopharm Int Sa |
Medicament for treatment of diabetic foot infections
|
SG11201809594WA
(en)
*
|
2016-06-30 |
2018-11-29 |
Philip Morris Products Sa |
Nicotine particles and compositions
|
JP7265984B2
(ja)
|
2016-10-21 |
2023-04-27 |
アディマブ, エルエルシー |
抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法
|
JP2020503844A
(ja)
|
2016-10-21 |
2020-02-06 |
アディマブ, エルエルシー |
抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法
|
JP2020503843A
(ja)
|
2016-10-21 |
2020-02-06 |
アディマブ, エルエルシー |
抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法
|
CN106727348B
(zh)
*
|
2016-12-20 |
2020-10-13 |
广州中大南沙科技创新产业园有限公司 |
防潮抗湿的低密度载体颗粒及其制备方法和应用
|
US20200146989A1
(en)
*
|
2016-12-23 |
2020-05-14 |
University Of Copenhagen |
A co-amorphous form of a substance and a dipeptide
|
US20220401365A1
(en)
*
|
2019-10-28 |
2022-12-22 |
Astrazeneca Ab |
Dry powder formulations containing leucine and trileucine
|
BR112022008031A2
(pt)
|
2019-10-28 |
2022-07-12 |
Medimmune Ltd |
Formulações de pó seco de anticorpos de ligação à linfopoietina estromal tímica (tslp) e métodos de uso das mesmas
|
WO2022148418A1
(fr)
*
|
2021-01-08 |
2022-07-14 |
江苏恒瑞医药股份有限公司 |
Composition pharmaceutique pouvant être administrée par inhalateur-doseur
|
TW202317080A
(zh)
|
2021-07-09 |
2023-05-01 |
美商阿斯特捷利康有限責任公司 |
用於氣溶膠遞送之組合物、方法及系統
|
US20230053812A1
(en)
*
|
2021-07-27 |
2023-02-23 |
Aurobindo Pharma Ltd |
Stable peptide formulations for oral use
|
WO2023091081A2
(fr)
*
|
2021-11-16 |
2023-05-25 |
Agency For Science, Technology And Research |
Formulation de poudre de protéine recombinante inhalable pour le traitement de troubles génétiques et auto-immuns
|
WO2023119093A1
(fr)
|
2021-12-20 |
2023-06-29 |
Astrazeneca Ab |
Compositions, procédés et systèmes d'administration d'un médicament en aérosol
|
WO2023212191A1
(fr)
|
2022-04-28 |
2023-11-02 |
Astrazeneca Ab |
Combinaison d'albutérol et de budésonide pour le traitement de l'asthme
|
WO2023229023A1
(fr)
*
|
2022-05-25 |
2023-11-30 |
学校法人 名城大学 |
Agent en poudre et son procédé de production
|